Subversive Mental Health ETF Rating $24.12 0.00 (0.00%) As of 03/27/2024 Add Compare Share Share Ratings Stock AnalysisRatings Subversive Mental Health ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SANE Aggregate RatingModerate Buy 2.77Holdings in SANE have an aggregate rating of Moderate Buy based on 218 analyst ratings issued in the past year covering 17 companies (73.5% of the portfolio).SANE Aggregate Price Target$24.12High Prediction$24.12Average Prediction$24.12Low Prediction$24.12Holdings in SANE have an aggregate price target of $24.12 and a range of $24.12 to $24.12 covering 17 companies (73.5% of the portfolio).SANE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Subversive Mental Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 SANE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.38%WSTWest Pharmaceutical Services$343.82+1.3%4.7416 of 5 stars2.83$430.20 25.1%6Dividend AnnouncementShort Interest ↑6.03%DXCMDexCom$87.62+1.4%4.9206 of 5 stars2.89$99.29 13.3%18Insider TradeShort Interest ↓4.87%ARCTArcturus Therapeutics$17.42+3.4%2.2751 of 5 stars3.13$61.60 253.6%8Analyst ForecastShort Interest ↑Gap Up4.85%ALKSAlkermes$31.91+1.1%3.7916 of 5 stars2.64$36.00 12.8%11Short Interest ↓Analyst RevisionNews Coverage4.69%LLYEli Lilly and Company$823.59+2.4%4.9877 of 5 stars2.81$997.22 21.1%21Upcoming EarningsAnalyst ForecastShort Interest ↑Analyst RevisionPositive News4.60%SNYSanofi$54.15+3.8%3.4351 of 5 stars3.00$60.00 10.8%3Earnings ReportAnalyst UpgradeOptions VolumeAnalyst RevisionNews CoverageGap Up4.53%TWSTTwist Bioscience$51.14+3.3%2.5907 of 5 stars2.70$51.90 1.5%10Upcoming EarningsInsider TradeNews Coverage4.40%UTHRUnited Therapeutics$352.30-5.5%4.3313 of 5 stars2.73$378.36 7.4%15Insider TradeShort Interest ↓Positive News4.40%SDGRSchrödinger$25.43+1.9%1.8335 of 5 stars2.80$32.11 26.3%104.22%GSKGSK$35.35+0.8%2.9139 of 5 stars2.67$43.25 22.3%9Upcoming Earnings4.11%BIIBBiogen$146.23+1.3%4.7672 of 5 stars2.43$228.80 56.5%28Analyst ForecastAnalyst Revision4.09%REGNRegeneron Pharmaceuticals$683.08-0.6%4.7289 of 5 stars2.65$1,004.57 47.1%23Analyst ForecastAnalyst Revision4.01%MRKMerck & Co., Inc.$98.91+0.6%4.9849 of 5 stars2.67$122.67 24.0%21Upcoming EarningsDividend AnnouncementAnalyst ForecastBuyback AnnouncementAnalyst RevisionPositive News3.63%CMPSCOMPASS Pathways$4.17+2.0%2.6908 of 5 stars3.00$33.60 705.8%63.49%BDXBecton, Dickinson and Company$248.34+0.6%4.9651 of 5 stars3.00$283.00 14.0%7Upcoming EarningsDividend AnnouncementAnalyst ForecastBuyback AnnouncementOptions Volume2.16%MDTMedtronic$92.01+0.7%4.8488 of 5 stars2.41$95.00 3.3%17Insider TradeShort Interest ↓Positive News2.06%DVADaVita$176.62+1.6%4.0472 of 5 stars2.00$161.80 -8.4%5Short Interest ↑News Coverage This page (BATS:SANE) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Subversive Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Subversive Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
